Guardian Pharmacy (GRDN) | Financial Analysis & Statements
Guardian Pharmacy Services Inc. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
397.6M
Gross Profit
85.5M
21.50%
Operating Income
30.8M
7.74%
Net Income
21.3M
5.35%
EPS (Diluted)
$0.33
Balance Sheet Metrics
Total Assets
412.7M
Total Liabilities
194.7M
Shareholders Equity
217.9M
Debt to Equity
0.89
Cash Flow Metrics
Operating Cash Flow
34.0M
Free Cash Flow
30.4M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Guardian Pharmacy Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.4B | 1.2B | 1.0B | 908.9M | 792.1M |
| Cost of Goods Sold | 1.2B | 984.0M | 837.9M | 723.0M | 630.8M |
| Gross Profit | 292.7M | 244.4M | 208.3M | 185.9M | 161.3M |
| Gross Margin % | 20.2% | 19.9% | 19.9% | 20.4% | 20.4% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 220.0M | 307.3M | 167.4M | 133.9M | 131.1M |
| Other Operating Expenses | - | - | - | -3.4M | - |
| Total Operating Expenses | 220.0M | 307.3M | 167.4M | 130.5M | 131.1M |
| Operating Income | 72.7M | -62.9M | 40.9M | 52.0M | 30.2M |
| Operating Margin % | 5.0% | -5.1% | 3.9% | 5.7% | 3.8% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 665.0K | 3.3M | 2.9M | 1.9M | 1.6M |
| Other Non-Operating Income | 1.4M | -279.0K | -367.0K | -403.0K | -187.0K |
| Pre-tax Income | 73.4M | -66.5M | 37.7M | 49.7M | 28.3M |
| Income Tax | 24.5M | 4.6M | 0 | - | - |
| Effective Tax Rate % | 33.3% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | 49.0M | -71.0M | 37.7M | 49.7M | 28.3M |
| Net Margin % | 3.4% | -5.8% | 3.6% | 5.5% | 3.6% |
| Key Metrics | |||||
| EBITDA | 96.4M | -43.4M | 58.8M | 68.2M | 46.5M |
| EPS (Basic) | - | $-1.77 | $0.00 | $0.58 | $0.27 |
| EPS (Diluted) | - | $-1.77 | $0.00 | $0.58 | $0.27 |
| Basic Shares Outstanding | - | 62005811 | 60844123 | 60844123 | 60844123 |
| Diluted Shares Outstanding | - | 62005811 | 60844123 | 60844123 | 60844123 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Guardian Pharmacy Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 65.6M | 4.7M | 752.0K | 607.0K | 15.0M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 101.6M | 97.2M | 77.3M | 67.8M | 55.2M |
| Inventory | 43.4M | 40.6M | 36.7M | 41.4M | 33.1M |
| Other Current Assets | 11.0M | 9.6M | 14.9M | 10.1M | 8.5M |
| Total Current Assets | 221.6M | 152.0M | 129.6M | 120.0M | 111.9M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 111.1M | 97.7M | 88.6M | 79.3M | 67.2M |
| Goodwill | 178.0M | 153.5M | 124.1M | 126.5M | 126.4M |
| Intangible Assets | 18.5M | 14.9M | 12.0M | 14.4M | 17.1M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 2.6M | 5.7M | 358.0K | 435.0K | 529.0K |
| Total Non-Current Assets | 191.0M | 168.8M | 141.6M | 136.1M | 124.0M |
| Total Assets | 412.7M | 320.8M | 271.2M | 256.1M | 235.8M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 116.2M | 102.4M | 85.6M | 78.1M | 64.6M |
| Short-term Debt | 7.2M | 6.8M | 19.2M | 13.5M | 9.6M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 22.3M | 20.4M | 16.2M | 6.5M | 8.7M |
| Total Current Liabilities | 160.7M | 144.1M | 138.0M | 112.0M | 111.5M |
| Non-Current Liabilities | |||||
| Long-term Debt | 30.0M | 23.3M | 41.8M | 43.3M | 40.8M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 4.0M | 3.4M | 31.5M | 24.9M | 3.0M |
| Total Non-Current Liabilities | 34.0M | 26.7M | 73.3M | 68.2M | 71.0M |
| Total Liabilities | 194.7M | 170.8M | 211.3M | 180.2M | 182.5M |
| Equity | |||||
| Common Stock | 63.0K | 63.0K | - | - | - |
| Retained Earnings | 66.3M | 17.1M | - | - | - |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 217.9M | 150.0M | 59.9M | 75.9M | 53.3M |
| Key Metrics | |||||
| Total Debt | 37.1M | 30.1M | 61.0M | 56.8M | 50.4M |
| Working Capital | 60.9M | 7.9M | -8.4M | 8.0M | 331.0K |
Balance Sheet Composition
Guardian Pharmacy Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 49.0M | -71.0M | 37.7M | 49.7M | 28.3M |
| Depreciation & Amortization | 22.3M | 19.8M | 18.2M | 16.6M | 16.5M |
| Stock-Based Compensation | 13.8M | 131.5M | -6.1M | -3.4M | 13.0M |
| Working Capital Changes | 5.8M | -26.4M | 12.6M | -18.7M | -1.5M |
| Operating Cash Flow | 95.1M | 54.6M | 62.7M | 44.4M | 56.3M |
| Investing Activities | |||||
| Capital Expenditures | -19.5M | -16.4M | -14.6M | -16.8M | -9.3M |
| Acquisitions | -13.4M | -14.7M | -985.0K | -2.0M | -4.4M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -32.2M | -30.4M | -13.4M | -17.9M | -13.1M |
| Financing Activities | |||||
| Share Repurchases | -29.0M | -55.2M | 0 | - | - |
| Dividends Paid | 0 | -35.8M | -38.4M | -30.8M | -17.4M |
| Debt Issuance | 0 | 15.0M | 0 | - | - |
| Debt Repayment | -5.0M | -240.8M | -272.4M | -255.8M | -17.1M |
| Financing Cash Flow | -7.1M | -221.9M | -321.7M | -294.0M | -47.8M |
| Free Cash Flow | 80.7M | 41.6M | 56.3M | 31.8M | 49.2M |
| Net Change in Cash | 55.8M | -197.8M | -272.4M | -267.5M | -4.6M |
Cash Flow Trend
Guardian Pharmacy Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
47.01
Forward P/E
27.08
Price to Book
11.29
Price to Sales
1.63
PEG Ratio
0.64
Profitability Ratios
Profit Margin
3.40%
Operating Margin
8.90%
Return on Equity
26.62%
Return on Assets
13.68%
Financial Health
Current Ratio
1.38
Debt to Equity
20.52
Per Share Data
EPS (TTM)
$0.78
Book Value per Share
$3.25
Revenue per Share
$23.22
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| GRDN | 2.4B | 47.01 | 11.29 | 26.62% | 3.40% | 20.52 |
| HCA Healthcare | 106.0B | 16.86 | -38.44 | -244.82% | 8.97% | -17.57 |
| Tenet Healthcare | 16.5B | 12.17 | 3.88 | 27.02% | 6.60% | 160.79 |
| Pacs | 5.5B | 28.73 | 5.80 | 22.96% | 3.62% | 377.77 |
| Chemed | 5.6B | 20.88 | 5.36 | 25.28% | 10.48% | 14.68 |
| Option Care Health | 4.5B | 22.35 | 3.36 | 15.20% | 3.67% | 96.00 |
Financial data is updated regularly. All figures are in the company's reporting currency.





